ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Renal ischemia"

  • 2017 American Transplant Congress

    How to Promote Regeneration After Ischemic Reperfusion Injury: Dual Role of CD 137 Agonistic Antibody.

    J. Lee,1,3 H. Kim,3 H. Chung,1 K. Park,1 B. Kwon,3,4 H. Cho.2,3

    1Internal Medicine, Ulsan University Hospital and College of Medicine, University of Ulsan, Ulsan, Korea; 2Surgery, Ulsan University Hospital and College of Medicine, University, Ulsan, Korea; 3Biomedical Research Center, Ulsan University Hospital, Ulsan, Korea; 4School of Biological Science, University of Ulsan, Ulsan, Korea

    Acute sterile inflammation can be induced by tissue damage caused by ischemia-reperfusion. In transplantation ischemia reperfusion injury (IRI) is unavoidable procedure. IRI causes delayed graft…
  • 2017 American Transplant Congress

    Nafamostat Mesilate Ameliorates Ischemia-Reperfusion Renal Injury via Anti-Apoptotic Mechanism.

    D. Choi,1 J. Jeong,2 H. Bae,1 Y. Ham,1 K. Lee,1 K. Na.1

    1Chungnam National University, Nephrology, Daejeon, Korea; 2Chungnam National University, Department of Medical Science, Daejeon, Korea

    Purpose: It has been reported that nafamostat mesilate inhibits inflammatory injury via inhibition of complement activation in ischemic heart, liver, and intestine. However, it is…
  • 2017 American Transplant Congress

    Postoperative Serum Lactate Dehydrogenase Is a "Troponin-Like" Marker of Renal Transplant Distress.

    R. Steiner, J. Halldorson.

    UCSD Center for Transplantation, University of California at San Diego, San Diego, CA

    Lactate dehydrogenase (LDH) is plentiful in renal tubular cells and is released during tubular injury or death. It increases for several days to 1500-2000 U/L…
  • 2017 American Transplant Congress

    Living Kidney Transplant: The Influence of Intraoperative Hemodynamics on Delayed Graft Function.

    R. Schutt,1 J. Case,1 B. Barrick,1 A. Toll,2 C. Marsh.1

    1Scripps Center for Organ and Cell Transplantation, Scripps Green Hospital, La Jolla, CA; 2Research Department and Analytics, UNOS, Richmond, VA

    Despite advantages of living donor kidneys, intraoperative insults may subject these kidneys to poor outcomes. Therefore, we investigated whether intraoperative fluid volumes and hemodynamics in…
  • 2017 American Transplant Congress

    Modulating Ischemia-Reperfusion Injuries with Pharmacological Agents: A Bench-to-Bedside Approach.

    M. Thomas, G. Tardif, A. Melanger, P. Berna.

    Balmes Transplantation, Marseille, France

    Ischemia–reperfusion (IR) is a complex pathophysiological process encompassing activation of inflammatory responses and cell death programs, the severity of which critically influences both the short…
  • 2017 American Transplant Congress

    Estrogen Receptor Alpha Mediates Female Protection from Renal Ischemia-Reperfusion Injury Through Mechanisms Extrinsic to the Kidney.

    D. Aufhauser,1 D. Murken,1 Z. Wang,1 G. Ge,1 S. Concors,1 T. Bhatti,2 W. Hancock,2,3 M. Levine.1,4

    1Surgery, University of Pennsylvania, Philadelphia, PA; 2Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA; 3Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA; 4Surgery, Children's Hospital of Philadelphia, Philadelphia, PA

    Introduction: Female protection from renal ischemia-reperfusion injury (IRI) is observed in both mouse and human renal transplantation. We wished to assess the role of estrogen…
  • 2017 American Transplant Congress

    Nuclear Co-Repressor Complex Inhibition Reverses Benefit of HDAC2 Deletion in Renal Ischemia.

    D. Aufhauser Jr,1 D. Murken,1 Z. Wang,1 A. Samanta,2 G. Ge,1 T. Bhatti,3 P. Cole,4 J. Kalin,4 W. Hancock,2,3 M. Levine.1,5

    1Surgery, University of Pennsylvania, Philadelphia, PA; 2Pathology, University of Pennsylvania, Philadelphia, PA; 3Pathology, Children's Hospital of Philadelphia, Philadelphia, PA; 4Pharmacology and Molecular Sciences, Johns Hopkins University, Baltimore, MD; 5Surgery, Children's Hospital of Philadelphia, Philadelphia, PA

    Introduction: Class I histone/protein deacetylases (HDACs) 1 and 2 bear >85% protein sequence homology and conventionally are thought to have similar function via occupancy in…
  • 2017 American Transplant Congress

    Evaluation of Outcomes in Renal Transplantation Using Machine Perfusion for the Preservation of Kidneys from Expanded Criteria Donor.

    E. Savoye, M. Macher, Kidney Working Group, C. Legeai, C. Antoine.

    Agence de la Biomedecine, Saint Denis La Plaine, France

    Introduction:The shortage of kidney grafts led to retrieve organs from old donors with one or more co-morbidities, considered as “expanded criteria donors” (ECD). In France,…
  • 2017 American Transplant Congress

    The Treatment of the Graft and the Recipient with α-Lipoic Acid Improves the Delay Graft Function Severity in the Human Kidney Transplant.

    G. Weber,1 N. Ambrosi,2 F. Caro,2 S. Beltramino,1 A. Fernández,1 I. Cabrera,1 G. Hilchenbach,1 D. Fernandez,1 C. Incardona,3 E. Chuluyan,2 D. Casadei.1

    1Instituto de Nefrologia, Nephrology, Buenos Aires, Argentina; 2CEFYBO, Facultad de Medicina, UBA-CONICET, Buenos Aires, Argentina; 3Fundación GADOR, Buenos Aires, Argentina

    A previous pilot clinic trial had showed that treatment of the donor and recipient with a potent anti-oxidant such as α-lipoc acid (ALA) reduces the…
  • 2017 American Transplant Congress

    Organs with Extended Cold Ischemia Time May Offer Aged Kidney Transplant Recipients New Options in an Expanded Donor Pool.

    M. Postalcioglu,1 B. Byun,1 A. Kaze,2 A. Siedlecki,1 E. Milford,2 R. Abdi.1

    1Transplantation Research Center, Brigham and Women's Hospital, Boston, MA; 2Renal Division, Brigham and Women's Hospital, Boston, MA

    Using data from the largest cohort of renal transplants, the aim of this study was to examine the effects of cold ischemia times (CIT) on…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 12
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences